Neutralizing antibody titres in SARS-CoV-2 infections

The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study

Parkinson patients' needs during COVID-19 pandemic in a red zone: a framework analysis of open-ended survey questions

The perceived impact of COVID-19 and associated restrictions on young people with epilepsy in the UK: Young people and caregiver survey

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Immunological characteristics govern the transition of COVID-19 to endemicity

Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape

Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia

Lessons from the COVID-19 pandemic for advancing computational drug repurposing strategies

Genetic variants of SARS-CoV-2—what do they mean?

Development and validation of a risk score using complete blood count to predict in-hospital mortality in COVID-19 Patients

Adaptive immunity to SARS-CoV-2 and COVID-19

MDA5 governs the innate immune response to SARS-CoV-2 in lung epithelial cells

Understanding the implications of SARS-CoV-2 re-infections on immune response milieu, laboratory tests and control measures against COVID-19

SARS-CoV-2 antibody testing for estimating COVID-19 prevalence in the population